Genentech demonstrates how pharma brands can reach younger patient communities with esports

Genentech, the pharma company, successfully used esports to connect with teenagers and young adults in the US with hemophilia, a rare disorder that reduces the ability of blood to clot.

This article is part of the May 2021 Spotlight US series, "How the pandemic has changed US healthcare marketing." Read more

Genentech is a biotechnology company on the forefront of treating people with hemophilia, a medical condition that significantly reduces the ability of blood to clot, through its Hemlibra brand of prescription medicine.

WARC subscribers can sign in to keep reading

Not a subscriber?

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

WARC consistently delivers valuable insights that help to make me look like an expert in front of my colleagues and clients.

Dasha Boryso
Strategy Partner, Fetch

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands